Gut-adipose tissue crosstalk: A bridge to novel therapeutic targets in metabolic syndrome?

Obes Rev. 2021 Feb;22(2):e13130. doi: 10.1111/obr.13130. Epub 2020 Aug 19.

Abstract

The gut is one of the main endocrine organs in our body, producing hormones acknowledged to play determinant roles in controlling appetite, energy balance and glucose homeostasis. One of the targets of such hormones is the adipose tissue, a major energetic reservoir, which governs overall metabolism through the secretion of adipokines. Disturbances either in nutrient and metabolic sensing and consequent miscommunication between these organs constitute a key driver to the metabolic complications clustered in metabolic syndrome. Thus, it is essential to understand how the disruption of this crosstalk might trigger adipose tissue dysfunction, a strong characteristic of obesity and insulin resistance. The beneficial effects of metabolic surgery in the amelioration of glucose homeostasis and body weight reduction allowed to understand the potential of gut signals modulation as a treatment for metabolic syndrome-related obesity and type 2 diabetes. In this review, we cover the effects of gut hormones in the modulation of adipose tissue metabolic and endocrine functions, as well as their impact in tissue plasticity. Furthermore, we discuss how the modulation of gut secretome, either through surgical procedures or pharmacological approaches, might improve adipose tissue function in obesity and metabolic syndrome.

Keywords: adipose tissue; gut hormones; metabolic surgery; obesity.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adipokines
  • Adipose Tissue / metabolism*
  • Diabetes Mellitus, Type 2
  • Gastrointestinal Tract / metabolism*
  • Humans
  • Insulin Resistance
  • Metabolic Syndrome* / drug therapy
  • Obesity

Substances

  • Adipokines